Topical Application of Fucoidan Improves Atopic Dermatitis Symptoms in NC/Nga Mice
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Fucoidan is a sulphated polysaccharide extracted from brown seaweed and possesses a wide range of pharmacological properties including antiallergic and immunologic activities. The present study attempted to examine the effectiveness of fucoidan from Undaria pinnatifida in the treatment of atopic dermatitis (AD) in the NC/Nga mice model. Three per cent fucoidan or 0.1% dexamethasone was topically applied to the dorsal skin of AD‐induced mice for 4 weeks. The dermatitis severity scores and scratch counts of fucoidan or dexamethasone‐treated animals were significantly lower than the control group. Histological analysis showed that the number of mast cells infiltrating into skin lesions and the epidermis thickness were significantly decreased after the treatments. Levels of serum histamine and IgE were also decreased. There was no significant difference on improvement of AD‐like symptoms between fucoidan and dexamethasone. To elucidate possible mechanism of action, effects of fucoidan on regulation of AD‐associated chemokines, such as thymus‐ and activation‐regulated chemokine (TARC), macrophage‐derived chemokine (MDC) and regulated upon activation, normal T‐cell expressed and secreted (RANTES) chemokine, were investigated in human epidermal keratinocytes. Fucoidan significantly inhibited mRNA expression of these chemokines in a dose‐dependent manner. This is the first animal study to demonstrate that fucoidan has significant effects on improving AD‐like conditions as effective as dexamethasone, a well‐recognized corticosteroid remedy for the disease. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New insights into atopic dermatitis
Leung, D. Y. M., Boguniewicz, M., Howell, M. D., Nomura, I., & Hamid, Q. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21060 · Cited by 1,435
Berteau, O. (2003) · Glycobiology · doi:10.1093/glycob/cwg058 · Cited by 769 · cited 1×
“Fucoidan is a dietary fibre purified from seaweed and represents a class of fucose-enriched sulphated polysaccharides found in the extracellular matrix of brown algae (Berteau and Mulloy, 2003).”
BackgroundImmunostimulatory effects of fucoidan on bone marrow-derived dendritic cells
Kim, M.-H., & Joo, H.-G. (2008) · Immunology Letters · doi:10.1016/j.imlet.2007.10.016 · Cited by 123 · cited 1×
“Fucoidan modulates the functions of immune cells such as macrophages, natural killer cells, lymphocytes and neutrophils (Nakamura et al., 2006; Kim and Joo, 2008).”
Background
Cited by
Therapies from Fucoidan: An Update
Fitton, J., Stringer, D., & Karpiniec, S. (2015) · Marine Drugs · doi:10.3390/md13095920 · Cited by 418
Fucoidan in pharmaceutical formulations: A comprehensive review for smart drug delivery systems
Haggag, Y., Abd Elrahman, A., Ulber, R., & Zayed, A. (2023) · Marine Drugs · doi:10.3390/md21020112 · Cited by 126
“The fucoidan/dexamethasonetreated group showed markedly less redness and erythema compared to the control group after 2 weeks of topical application [77].”
BackgroundThe Pharmacokinetics of Fucoidan after Topical Application to Rats
Pozharitskaya, O. N., Shikov, A. N., Obluchinskaya, E. D., & Vuorela, H. (2019) · Marine Drugs · doi:10.3390/md17120687 · Cited by 79
“The topical application of formulations containing fucoidan has been reported as an effective method for the treatment of atopic dermatitis, dermal burns, oral herpes, and as an anticoagulant [11,12,15,23].”
Method
Metadata
- Authors
- Yang, J.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2012-03-19
- Volume
- 26
- Issue
- 12
- Pages
- 1898-1903
- ISSN
- 0951-418X (ISSN-L)
- 1099-1573
- OpenAlex
- W2137084209
- Cited by
- 49
- References
- 3
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.